These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27329439)

  • 1. A pharmacoeconomic approach to assessing the costs and benefits of air quality interventions that improve health: a case study.
    Lomas J; Schmitt L; Jones S; McGeorge M; Bates E; Holland M; Cooper D; Crowther R; Ashmore M; Rojas-Rueda D; Weatherly H; Richardson G; Bojke L
    BMJ Open; 2016 Jun; 6(6):e010686. PubMed ID: 27329439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation.
    Thomas C; Sadler S; Breeze P; Squires H; Gillett M; Brennan A
    BMJ Open; 2017 Aug; 7(8):e014953. PubMed ID: 28827235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost-efficiency and health benefit approach to improve urban air quality.
    Miranda AI; Ferreira J; Silveira C; Relvas H; Duque L; Roebeling P; Lopes M; Costa S; Monteiro A; Gama C; Sá E; Borrego C; Teixeira JP
    Sci Total Environ; 2016 Nov; 569-570():342-351. PubMed ID: 27348699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causal Inference Methods for Estimating Long-Term Health Effects of Air Quality Regulations.
    Zigler CM; Kim C; Choirat C; Hansen JB; Wang Y; Hund L; Samet J; King G; Dominici F;
    Res Rep Health Eff Inst; 2016 May; (187):5-49. PubMed ID: 27526497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the cost-effectiveness of salt reformulation and increasing access to leisure centres in England, with PRIMEtime CE model validation using the AdViSHE tool.
    Briggs ADM; Wolstenholme J; Scarborough P
    BMC Health Serv Res; 2019 Jul; 19(1):489. PubMed ID: 31307459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the health benefits of air pollution reduction for children.
    Wong EY; Gohlke J; Griffith WC; Farrow S; Faustman EM
    Environ Health Perspect; 2004 Feb; 112(2):226-32. PubMed ID: 14754578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain.
    Sanchez-Luna M; Burgos-Pol R; Oyagüez I; Figueras-Aloy J; Sánchez-Solís M; Martinón-Torres F; Carbonell-Estrany X
    BMC Infect Dis; 2017 Oct; 17(1):687. PubMed ID: 29041909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ex post cost-benefit analysis of the nitrogen dioxide air pollution control program in Tokyo.
    Voorhees AS; Araki S; Sakai R; Sato H
    J Air Waste Manag Assoc; 2000 Mar; 50(3):391-410. PubMed ID: 10734711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of the congestion charging scheme on air quality in London. Part 1. Emissions modeling and analysis of air pollution measurements.
    Kelly F; Anderson HR; Armstrong B; Atkinson R; Barratt B; Beevers S; Derwent D; Green D; Mudway I; Wilkinson P;
    Res Rep Health Eff Inst; 2011 Apr; (155):5-71. PubMed ID: 21830496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fuels for urban transit buses: a cost-effectiveness analysis.
    Cohen JT; Hammitt JK; Levy JI
    Environ Sci Technol; 2003 Apr; 37(8):1477-84. PubMed ID: 12731827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health benefits of a reduction of PM
    Castro A; Künzli N; Götschi T
    Int J Hyg Environ Health; 2017 Jul; 220(5):829-839. PubMed ID: 28411064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased use of 6-monthly gonadotropin-releasing hormone agonist therapy for prostate cancer: a capacity and cost-minimization analysis for England.
    Cornford P; Halpin C; Sassmann J; Frankcom I; Braybrook S
    J Med Econ; 2023; 26(1):208-218. PubMed ID: 36749636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of health benefits related to air quality improvement strategies in urban areas: An Impact Pathway Approach.
    Silveira C; Roebeling P; Lopes M; Ferreira J; Costa S; Teixeira JP; Borrego C; Miranda AI
    J Environ Manage; 2016 Dec; 183(Pt 3):694-702. PubMed ID: 27641656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Including Costs and Outcomes of Dementia in a Health Economic Model to Evaluate Lifestyle Interventions to Prevent Diabetes and Cardiovascular Disease.
    Breeze P; Thomas C; Thokala P; Lafortune L; Brayne C; Brennan A
    Med Decis Making; 2020 Oct; 40(7):912-923. PubMed ID: 32951510
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.